Janneke van der Kamp

CEO at Norgine

Speaker

Janneke van der Kamp is Chief Executive Officer of Norgine, a mid-sized EU-based pharmaceutical company with 1,500 employees and approximately $600 million in annual sales. Innovation drives Norgine’s mission to deliver medicines that change lives, addressing unmet medical needs from common conditions like constipation to rare and severe diseases such as childhood cancer. Janneke brings over two decades of pharmaceutical leadership experience, having held senior roles at Novartis — including Head of Pharma Region Europe — and served as Chief Commercial Officer at Grünenthal. Janneke is driving forward Norgine's strategy that combines in-house innovation with strategic partnerships to expand its portfolio and pursue assets in areas of high unmet need. She is also fostering a culture of empowerment, collaboration, and purpose-driven impact.